Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: pathology

TriPath Imaging and Ventana Sign Major Development Pact

Pathology Trends / By Robert Michel

IF THE NEW BUSINESS AGREEMENT between Ventana Medical Systems, Inc. and TriPath Imaging, Inc. is successful, then the anatomic pathology laboratory may have a very different look in future years. Last week, Ventana Medical Systems, Inc. announced a five-year global supply agreement with TriPath Imaging, Inc. that involves two primary objectives. First, Ventana will put …

TriPath Imaging and Ventana Sign Major Development Pact Read More »

To access this post, you must purchase The Dark Report.

“September 20, 2004 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By Robert Michel

Ventana Medical Systems, Inc. now has access to Qdot® nanocrystal technology for in vitro diagnostic applications in anatomic pathology and cytology. Ventana recently licensed the technology from Quantum Dot Corporation (QDC), based in Hayward California. It will use Qdots to create “next generation rapid, quantitative, and multiplexed assays for cancer diagnosis and disease management.” Qdots …

“September 20, 2004 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

ChromaVision Targets National AP Market

Pathology Trends / By Robert Michel

CEO SUMMARY: Three new business strategies are moving ChromaVision into different segments of the laboratory testing marketplace. The company has built a new laboratory facility and will support local pathology groups with advanced diagnostic technology. It is also expanding its presence in the research and development area of pharmacodiagnostics, with an emphasis on oncology. PROFIT …

ChromaVision Targets National AP Market Read More »

To access this post, you must purchase The Dark Report.

Oncology’s Potential Drives AP Lab Expansion

Anatomic Pathology / By Robert Michel

CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are giving physicians more effective ways to detect cancer and treat it. That …

Oncology’s Potential Drives AP Lab Expansion Read More »

To access this post, you must purchase The Dark Report.

“August 30, 2004 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By Robert Michel

Film-maker Michael Moore is ready to turn his cameras on the American healthcare system. During a tour of the United Kingdom this summer, the controversial director declared that he wanted to use his cameras to intervene and save lives. Moore, basking in the attention generated by his Fahrenheit 9/11 film, wants to “embarrass” health insurance …

“August 30, 2004 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

“Actionable Intelligence” In Real Time

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

BEFORE YOU READ THIS ISSUE, I would like to make three observations. Each will help you get maximum value from the information contained herein about the trend of in-house anatomic pathology (AP) laboratories in specialist physician groups. First, THE DARK REPORT’S coverage of this trend is unmatched by any other source in the lab industry. …

“Actionable Intelligence” In Real Time Read More »

To access this post, you must purchase The Dark Report.

Of Congress and the OIG: Speedy Action Ahead?

Pathology Trends / By Robert Michel

CEO SUMMARY: During the short life of AP laboratory condominium complexes, they have attracted the interest of both an influential Senator and the Office of the Inspector General (OIG). Last month, Senator Charles E. Grassley sent a letter to the OIG requesting that it investigate the AP lab condo scheme and report its findings to …

Of Congress and the OIG: Speedy Action Ahead? Read More »

To access this post, you must purchase The Dark Report.

AP Test Over-Utilization Will Be One Achilles’ Heel

Pathology Trends / By Robert Michel

CEO SUMMARY: Over-utilization is likely to be a prime concern when federal healthcare enforcers eventually investigate in-house anatomic pathology laboratories owned by specialist physicians. Some in-house pathology lab condo promoters are basing financial performance on 100% utilization of 12-core prostate biopsies. That significantly exceeds current clinical practices, as the numbers below demonstrate. OVER-UTILIZATION WILL BE …

AP Test Over-Utilization Will Be One Achilles’ Heel Read More »

To access this post, you must purchase The Dark Report.

Exposed: Who Created Path Lab Condo Scheme

Pathology Trends / By Robert Michel

CEO SUMMARY: It wasn’t pathologists and it wasn’t laboratory executives who started this scheme. Anatomic pathology condominium laboratory complexes were conceived by urologists in Florida. Some Texas urologists jumped on the bandwagon early, becoming enthusiastic promoters of the scheme to other specialist physicians. That’s why Florida and Texas are the hotbed states for this movement. …

Exposed: Who Created Path Lab Condo Scheme Read More »

To access this post, you must purchase The Dark Report.

Visit To A Path Condo Lab: “You Are Not Welcome”

Pathology Trends / By Robert Michel

NO “WELCOME MAT” greets visitors to an anatomic pathology (AP) condominium complex. That was certainly true last month when an agent of THE DARK REPORT attempted to visit a lab condo complex in San Antonio, Texas. Operated by UroPath, LLC, the lab condo complex is located at 7909 Fredericksburg Road in Suite 150. Also in …

Visit To A Path Condo Lab: “You Are Not Welcome” Read More »

To access this post, you must purchase The Dark Report.

;